Skip to main content Skip to secondary navigation
Main content start
Bioengineering

Caitlyn Miller

Advisors: Carolyn Bertozzi and Jennifer Cochran

Despite recent advances in cancer research, pancreatic adenocarcinoma remains one of the deadliest solid malignancies due in part to its resistance to systemic therapies. Studies have revealed that limited therapeutic delivery and immune evasion are two key elements contributing to this therapeutic resistance. Eliminating factors that regulate these physical and biochemical barriers is a promising approach to improve delivery, abate immune evasion, and stimulate an anti-tumor immune response. My research is currently focused on synthesizing tumor-targeting agents that modulate these resistance mechanisms to enhance immunotherapy for pancreatic cancer. 

Stanford Affiliations